おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Lucira Health
company
About
Lucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases.
- 251 - 500
Details
- Last Funding Type
- Post-IPO Debt
- Last Funding Money Raised
- $80M
- Industries
- Biotechnology,Health Care,Health Diagnostics
- Founded date
- Jan 1, 2013
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Lucira Health is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. Lucira has developed a testing platform that produces centralized-laboratory-accurate molecular testing in a single-use and consumer-friendly test kit that is powered by two AA batteries and fits in the palm of a hand.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$80.26M
Lucira Health has raised a total of
$80.26M
in funding over 2 rounds. Their latest funding was raised on
Feb 4, 2022 from a Post-IPO Debt round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 4, 2022 | Post-IPO Debt | $80M | 1 |
Hercules Capital
|
— | Detail |
| Dec 18, 2014 | Grant | $269.88K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
2
Lucira Health is funded by 2 investors.
Hercules Capital
and National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Hercules Capital
|
Yes | Post-IPO Debt |
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
